Have a personal or library account? Click to login

The impact of glutamine deprivation on the expression of MEIS3, SPAG4, LHX1, LHX2, and LHX6 genes in ERN1 knockdown U87 glioma cells

Open Access
|Feb 2022

References

  1. Alimohammadi E, Bagheri SR, Salehi AS, Rizevandi P, Rezaie Z, Abdi A. Prognostic factors in patients with glioblastoma multiforme: focus on the pathologic variants. Acta Neurol Belg 120, 1341–1350, 2020.10.1007/s13760-019-01171-x31222512
  2. Almanza A, Carlesso A, Chintha C, Creedican S, Doultsinos D, Leuzzi B, Luis A, McCarthy N, Montibeller L, More S, Papaioannou A, Puschel F, Sassano ML, Skoko J, Agostinis P, de Belleroche J, Eriksson LA, Fulda S, Gorman AM, Healy S, Kozlov A, Muñoz-Pinedo C, Rehm M, Chevet E, Samali A. Endoplasmic reticulum stress signalling – from basic mechanisms to clinical applications. FEBS J 286, 241–278, 2019.10.1111/febs.14608737963130027602
  3. Auf G, Jabouille A, Guerit S, Pineau R, Delugin M, Bouchecareilh M, Favereaux A, Maitre M, Gaiser T, von Deimling A, Czabanka M, Vajkoczy P, Chevet E, Bikfalvi A, Moenner M. A shift from an angiogenic to invasive phenotype induced in malignant glioma by inhibition of the unfolded protein response sensor IRE1. Proc Natl Acad Sci USA 107, 15553–15558, 2010.10.1073/pnas.0914072107293260020702765
  4. Auf G, Jabouille A, Delugin M, Guerit S, Pineau R, North S, Platonova N, Maitre M, Favereaux A, Vajkoczy P, Seno M, Bikfalvi A, Minchenko D, Minchenko O, Moenner M. High epiregulin expression in human U87 glioma cells relies on IRE1alpha and promotes autocrine growth through EGF receptor. BMC Cancer 13, 597, 2013.10.1186/1471-2407-13-597387867024330607
  5. Awale S, Lu J, Kalauni SK, Kurashima Y, Tezuka Y, Kadota S, Esumi H. Identification of arctigenin as an antitumor agent having the ability to eliminate the tolerance of cancer cells to nutrient starvation. Cancer Res 66, 1751–1757, 2006.10.1158/0008-5472.CAN-05-314316452235
  6. Bravo R, Parra V, Gatica D, Rodriguez AE, Torrealba N, Paredes F, Wang ZV, Zorzano A, Hill JA, Jaimovich E, Quest AF, Lavandero S. Endoplasmic reticulum and the unfolded protein response: dynamics and metabolic integration. Int Rev Cell Mol Biol 301, 215–290, 2013.10.1016/B978-0-12-407704-1.00005-1366655723317820
  7. Chen HQ, Zhao J, Li Y, Huang YJ, Chen DJ, He LX, Wang LQ, Zheng CF, Wang J, Cao J, Shu WQ, Liu JY, Liu WB. Epigenetic inactivation of LHX6 mediated microcystin-LR induced hepatocarcinogenesis via the Wnt/beta-catenin and P53 signaling pathways. Environ Pollut 252, 216–226, 2019.10.1016/j.envpol.2019.05.04931151060
  8. Colombo SL, Palacios-Callender M, Frakich N, Carcamo S, Kovacs I, Tudzarova S, Moncada S. Molecular basis for the differential use of glucose and glutamine in cell proliferation as revealed by synchronized HeLa cells. Proc Natl Acad Sci USA 108, 21069–21074, 2011.10.1073/pnas.1117500108324854322106309
  9. Doultsinos D, Avril T, Lhomond S, Dejeans N, Guédat P, Chevet E. Control of the Unfolded Protein Response in Health and Disease. SLAS Discov 22, 787–800, 2017.10.1177/247255521770168528453376
  10. Drogat B, Bouchecareilh M, North S, Petibois C, Deleris G, Chevet E, Bikfalvi A, Moenner M. Acute L-glutamine deprivation compromises VEGF-a upregulation in A549/8 human carcinoma cells. J Cell Physiol 212, 463–472, 2007.10.1002/jcp.2104417348020
  11. Ghiaghi M, Forouzesh F, Rahimi H. Effect of Sodium Butyrate on LHX1 mRNA Expression as a Transcription Factor of HDAC8 in Human Colorectal Cancer Cell Lines. Avicenna J Med Biotechnol 11, 317–324, 2019.
  12. Girgin B, Karadag-Alpaslan M, Kocabas F. Oncogenic and tumor suppressor function of MEIS and associated factors. Turk J Biol 44, 328–355, 2020.10.3906/biy-2006-25775919733402862
  13. Guca E, Sunol D, Ruiz L, Konkol A, Cordero J, Torner C, Aragon E, Martin-Malpartida P, Riera A, Macias MJ. TGIF1 homeodomain interacts with Smad MH1 domain and represses TGF-beta signaling. Nucleic Acids Res 46, 9220–9235, 2018.10.1093/nar/gky680615871730060237
  14. Hamaidi I, Coquard C, Danilin S, Dormoy V, Beraud C, Rothhut S, Barthelmebs M, Benkirane-Jessel N, Lindner V, Lang H, Massfelder T. The Lim1 oncogene as a new therapeutic target for metastatic human renal cell carcinoma. Oncogene 38, 60–72, 2019.10.1038/s41388-018-0413-y30076415
  15. He Y, Fan Q, Cai T, Huang W, Xie X, Wen Y, Shi Z. Molecular Mechanisms of the Action of Arctigenin in Cancer. Biomed Pharmacother 108, 403–407, 2018.10.1016/j.biopha.2018.08.15830236849
  16. Hetz C, Axten JM, Patterson JB. Pharmacological targeting of the unfolded protein response for disease intervention. Nat Chem Biol 15, 764–775, 2019.10.1038/s41589-019-0326-231320759
  17. Ji Y, Jiang J, Huang L, Feng W, Zhang Z, Jin L, Xing X. Spermassociated antigen 4 (SPAG4) as a new cancer marker interacts with Nesprin3 to regulate cell migration in lung carcinoma. Oncol Rep 40, 783–792, 2018.10.3892/or.2018.6473607230129901114
  18. Kim JY, Hwang JH, Cha MR, Yoon MY, Son ES, Tomida A, Ko B, Song SW, Shin-ya K, Hwang YI, Park HR. Arctigenin Blocks the Unfolded Protein Response and Shows Therapeutic Antitumor Activity. J Cell Physiol 224, 33–40, 2010.10.1002/jcp.2208520232300
  19. Knaup KX, Monti J, Hackenbeck T, Jobst-Schwan T, Klanke B, Schietke RE, Wacker I, Behrens J, Amann K, Eckardt KU, Warnecke C, Wiesener MS. Hypoxia regulates the sperm associated antigen 4 (SPAG4) via HIF, which is expressed in renal clear cell carcinoma and promotes migration and invasion in vitro. Mol Carcinog 53, 970–978, 2014.10.1002/mc.2206523818324
  20. Le Magnen C, Virk RK, Dutta A, Kim JY, Panja S, Lopez-Bujanda ZA, Califano A, Drake CG, Mitrofanova A, Abate-Shen C. Cooperation of loss of NKX3.1 and inflammation in prostate cancer initiation. Dis Model Mech 11, dmm035139, 2018.10.1242/dmm.035139626281930266798
  21. Li Q, Ma L, Wu Z, Wang G, Huang Q, Shen Z, Yu R. Zinc finger Ebox binding homeobox 2 functions as an oncogene in human laryngeal squamous cell carcinoma. Mol Med Rep 19, 4545–4552, 2019.10.3892/mmr.2019.10126652280330957184
  22. Liang TS, Zheng YJ, Wang J, Zhao JY, Yang DK, Liu ZS. MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/beta-catenin signaling pathway by down-regulating LHX2. J Exp Clin Cancer Res 38, 97, 2019.10.1186/s13046-019-1023-4638544930791932
  23. Liao J, Lin J, Lin D, Zou C, Kurata J, Lin R, He Z, SuY. Down-regulation of miR-214 reverses erlotinib resistance in non-small-cell lung cancer through up-regulating LHX6 expression. Sci Rep 7, 781, 2017.10.1038/s41598-017-00901-6542970728396596
  24. Liu Z, Dai J, Shen H. Systematic analysis reveals long noncoding RNAs regulating neighboring transcription factors in human cancers. Biochim Biophys Acta Mol Basis Dis 1864, 2785–2792, 2018.10.1016/j.bbadis.2018.05.00629753811
  25. Logue SE, McGrath EP, Cleary P, Greene S, Mnich K, Almanza A, Chevet E, Dwyer RM, Oommen A, Legembre P, Godey F, Madden EC, Leuzzi B, Obacz J, Zeng Q, Patterson JB, Jäger R, Gorman AM, Samali A. Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy. Nat Commun 9, 3267, 2018.10.1038/s41467-018-05763-8609393130111846
  26. Manié SN, Lebeau J, Chevet E. Cellular mechanisms of endoplasmic reticulum stress signaling in health and disease. 3. Orchestrating the unfolded protein response in oncogenesis: an update. Am J Physiol Cell Physiol 307, C901–C907, 2014.10.1152/ajpcell.00292.201425186011
  27. Minchenko DO, Kharkova AP, Hubenia OV, Minchenko OH. Insulin receptor, IRS1, IRS2, INSIG1, INSIG2, RRAD, and BAIAP2 gene expressions in glioma U87 cells with ERN1 loss of function: effect of hypoxia and gluta-mine or glucose deprivation. Endocr Reg 47, 15–26, 2013.10.4149/endo_2013_01_1523363253
  28. Minchenko DO, Danilovskyi SV, Kryvdiuk IV, Bakalets TV, Lypova NM, Karbovskyi LL, Minchenko OH. Inhibition of ERN1 modifies the hypoxic regulation of the expression of TP53-related genes in U87 glioma cells. Endoplasm Reticul Stress Dis 1, 18–26, 2014.10.2478/ersc-2014-0001
  29. Minchenko DO, Kharkova AP, Tsymbal DO, Karbovskyi LL, Minchenko OH. IRE1 inhibition affects the expression of insulin-like growth factor binding protein genes and modifies its sensitivity to glucose deprivation in U87 glioma cells. Endocr Reg 49, 185–197, 2015a.10.4149/endo_2015_04_18526494037
  30. Minchenko OH, Tsymbal DO, Minchenko DO, Kovalevska OV, Karbovskyi LL, Bikfalvi A. Inhibition of ERN1 signaling enzyme affects hypoxic regulation of the expression of E2F8, EPAS1, HOXC6, ATF3, TBX3 and FOXF1 genes in U87 glioma cells. Ukr Biochem J 87(2): 76–87, 2015b.10.15407/ubj87.02.076
  31. Minchenko OH, Tsymbal DO, Moenner M, Kovalevska OV, Lypova NM. Inhibition of the endoribonuclease of ERN1 signaling enzyme affects the expression of proliferation-related genes in U87 glioma cells. Endoplasm Reticul Stress Dis 2, 18–29, 2015c.10.1515/ersc-2015-0002
  32. Minchenko OH, Tsymbal DO, Minchenko DO, Hnatiuk OS, Prylutskyy YI, Prylutska SV, Tsierkezos NG, Ritter U. Single-walled carbon nanotubes affect the expression of genes associated with immune response in normal human astrocytes. Toxicology in vitro 52, 122–130, 2018.10.1016/j.tiv.2018.06.01129906516
  33. Minchenko DO, Khita OO, Tsymbal DO, Viletska YM, Sliusar MY, Yefimova YV, Levadna LO, Krasnytska DA, Minchenko OH. ERN1 knockdown modifies the impact of glucose and glutamine deprivations on the expression of EDN1 and its receptors in glioma cells. Endocr Reg 55, 72–82, 2021.10.2478/enr-2021-000934020533
  34. Miyashita K, Kitajima K, Goyama S, Kitamura T, Hara T. Overexpression of Lhx2 suppresses proliferation of human T cell acute lymphoblastic leukemia-derived cells, partly by reducing LMO2 protein levels. Biochem Biophys Res Commun 495, 2310–2316, 2018.10.1016/j.bbrc.2017.12.13529278703
  35. Nathalia E, Theardy MS, Elvira S, Rosellinny G, Liyanto AS, Utama MP, Sumarpo A. Downregulation of tumor-suppressor gene LHX6 in cancer: a systematic review. Rom J Intern Med 56, 135–142, 2018.10.2478/rjim-2018-000829533904
  36. Obacz J, Avril T, Le Reste PJ, Urra H, Quillien V, Hetz C, Chevet E. Endoplasmic reticulum proteostasis in glioblastoma-From molecular mechanisms to therapeutic perspectives. Sci Signal 10(470), pii: eaal2323, 2017.10.1126/scisignal.aal232328292956
  37. Papaioannou A, Chevet E. Driving Cancer Tumorigenesis and Metastasis Through UPR Signaling. Curr Top Micro-biol Immunol 414, 159–192, 2018.10.1007/82_2017_3628710693
  38. Riabovol OO, Tsymbal DO, Minchenko DO, Lebid-Biletska KM, Sliusar MY, Rudnytska OV, Minchenko OH. Effect of glucose deprivation on the expression of genes encoding glucocorticoid receptor and some related factors in ERN1-knockdown U87 glioma cells. Endocr Regul 53, 237–249, 2019.10.2478/enr-2019-002431734653
  39. Song H, Liu J, Wu X, Zhou Y, Chen X, Chen J, Deng K, Mao C, Huang S, Liu Z. LHX2 promotes malignancy and inhibits autophagy via mTOR in osteosarcoma and is negatively regulated by miR-129-5p. Aging (Albany NY) 11, 9794–9810, 2019.10.18632/aging.102427687443231724536
  40. Tsymbal DO, Minchenko DO, Kryvdiuk IV, Riabovol OO, Halkin OV, Ratushna OO, Minchenko OH. Expression of proliferation related transcription factor genes in U87 glioma cells with IRE1 knockdown upon glucose and glutamine deprivation. Fiziol Zh 62, 3–15, 2016.10.15407/fz62.01.00329537195
  41. Wang Y, Tang Y, Li J, Wang D, Li W. Human sperm-associated antigen 4 as a potential prognostic biomarker of lung squamous cell carcinoma. J Int Med Res 49, 03000605211032807, 2021.10.1177/03000605211032807832057334311595
  42. Yalcin A, Clem BF, Imbert-Fernandez Y, Ozcan SC, Peker S, O’Neal J, Klarer AC, Clem AL, Telang S, Chesney J. 6-Phosphofructo-2-kinase (PFKFB3) promotes cell cycle progression and suppresses apoptosis via Cdk1-mediated phosphorylation of p27. Cell Death and Disease 5, e1337, 2014.10.1038/cddis.2014.292412308625032860
  43. Yalim-Camci I, Balcik-Ercin P, Cetin M, Odabas G, Tokay N, Sayan AE, Yagci T. ETS1 is coexpressed with ZEB2 and mediates ZEB2-induced epithelial-mesenchymal transition in human tumors. Mol Carcinog 58, 1068–1081, 2019.10.1002/mc.2299430790340
  44. Yan L, Cai K, Sun K, Gui J, Liang J. MiR-1290 promotes proliferation, migration, and invasion of glioma cells by targeting LHX6. J Cell Physiol 233, 6621–6629, 2018.10.1002/jcp.2638129226322
  45. Zhang C, Wang M, Ji F, Peng Y, Wang B, Zhao J, Wu J, Zhao H. A Novel Glucose Metabolism-Related Gene Signature for Overall Survival Prediction in Patients with Glioblastoma. Biomed Res Int 2021, 8872977, 2021.10.1155/2021/8872977784733633553434
  46. Zhang Y, Pan Q, Shao Z. Tumor-Suppressive Role of microRNA-202-3p in Hepatocellular Carcinoma Through the KDM3A/HOXA1/MEIS3 Pathway. Front Cell Dev Biol 8, 556004, 2020.10.3389/fcell.2020.556004784352533520978
  47. Zhao S, Cai J, Li J, Bao G, Li D, Li Y, Zhai X, Jiang C, Fan L. Bioinformatic Profiling Identifies a Glucose-Related Risk Signature for the Malignancy of Glioma and the Survival of Patients. Mol Neurobiol 54, 8203–8210, 2017.10.1007/s12035-016-0314-427900679
DOI: https://doi.org/10.2478/enr-2022-0005 | Journal eISSN: 1336-0329 | Journal ISSN: 1210-0668
Language: English
Page range: 38 - 47
Published on: Feb 18, 2022
Published by: Slovak Academy of Sciences, Mathematical Institute
In partnership with: Paradigm Publishing Services
Publication frequency: 1 times per year

© 2022 Dariia A. Krasnytska, Olena O. Khita, Dariia O. Tsymbal, Olha Y. Luzina, Anastasiia A. Cherednychenko, Halyna E. Kozynkevich, Borys H. Bezrodny, Dmytro O. Minchenko, published by Slovak Academy of Sciences, Mathematical Institute
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.